Beacon Equity Research: Hemispherx BioPharma (HEB) Surges Higher with Recent Developments
Hemispherx BioPharma, Inc (AMEX:HEB) continues to surge today and has gained 49.4% from my alert yesterday at $.33. HEB has traded as high as $.494 during today’s trading session and last traded at $.493 for a gain of 20.18% from Friday’s close! HEB shares have traded as high as $.57 over the past 52 weeks, which is 13.5% off that high at last traded stock price. On January 11, the Food and Drug Administration FDA granted an extension for the Company to modify its New Drug Application NDA in response to a Complete Response Letter CRL received November 25, 2009…